APA

Stein D. S., Jain J. P., Kangas M., Lefèvre G., Machineni S., Griffin P. & Lickliter J. (20160216). Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquine. : Antimicrobial agents and chemotherapy.

Chicago

Stein Daniel S, Jain Jay Prakash, Kangas Michael, Lefèvre Gilbert, Machineni Surendra, Griffin Paul and Lickliter Jason. 20160216. Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquine. : Antimicrobial agents and chemotherapy.

Harvard

Stein D. S., Jain J. P., Kangas M., Lefèvre G., Machineni S., Griffin P. and Lickliter J. (20160216). Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquine. : Antimicrobial agents and chemotherapy.

MLA

Stein Daniel S, Jain Jay Prakash, Kangas Michael, Lefèvre Gilbert, Machineni Surendra, Griffin Paul and Lickliter Jason. Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquine. : Antimicrobial agents and chemotherapy. 20160216.